Effects of a 12-Week Waltz Dance Intervention on Cardiovascular Health in Women Aged 45-65 With Dyslipidemia

Launched by GDANSK UNIVERSITY OF PHYSICAL EDUCATION AND SPORT · Jul 2, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring whether taking Waltz dance classes can help improve heart and bone health in women aged 45 to 65 who have dyslipidemia, which means they have unhealthy levels of fats like cholesterol or triglycerides in their blood. The study wants to find out if dancing the Waltz three times a week for 12 weeks can lower bad cholesterol, raise good cholesterol, improve fitness, help with body weight and muscle, support healthy blood vessels, and strengthen bones. To do this, researchers will compare women who take the dance classes with those who keep their usual lifestyle.

Women who might be eligible for the study are those between 45 and 65 years old who have been told by a doctor that their blood fat levels are outside the healthy range and who don’t currently exercise regularly. Participants will attend supervised dance sessions lasting about 1 hour and 45 minutes, three times a week for 12 weeks. Before and after the program, they will have simple physical tests and blood samples taken to check for changes in their health. They will also wear a small device to track their physical activity during the study. Women with certain health conditions, such as serious heart problems or severe bone disease, won’t be able to join to keep everyone safe. This study aims to see if a fun activity like dancing can be a helpful way to improve important aspects of health in women with dyslipidemia.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Female participants aged between 45 and 65 years.
• • 2. Diagnosed with dyslipidemia (based on clinical lipid profile: TC ≥ 6.2 mmol/L, TG ≥ 2.3 mmol/L, LDL-C ≥ 4.1 mmol/L, or HDL-C \< 1.0 mmol/L).
• • 3. Sedentary lifestyle (less than 60 minutes of structured physical activity per week in the last 6 months).
• • 4. Able to participate safely in moderate-intensity exercise as confirmed by a medical evaluation.
• • 5. Willing to participate in a 12-week supervised exercise program, 3 times per week.
• • 6. Able to understand study procedures and provide written informed consent.
• Exclusion Criteria:
• • 1. Diagnosis of cardiovascular disease requiring medical supervision during exercise (e.g., unstable angina, recent myocardial infarction).
• • 2. Severe musculoskeletal disorders (e.g., advanced osteoarthritis, recent fractures) limiting mobility or physical activity.
• • 3. Neurological or cognitive disorders affecting motor function or communication.
• • 4. Uncontrolled hypertension (SBP ≥ 160 mmHg or DBP ≥ 100 mmHg at rest).
• • 5. Diagnosed osteoporosis with high fracture risk (T-score ≤ -2.5 and history of fragility fractures).
• • 6. Any endocrine disorder that significantly affects lipid metabolism (e.g., uncontrolled thyroid disease, Cushing's syndrome).
• • 7. Participation in structured exercise or dance programs within the past 12 months.
• • 8. Current use of medications significantly affecting lipid levels (e.g., high-dose statins) unless dose has been stable for at least 3 months.
• • 9. Any condition judged by the investigator to interfere with safe participation in the study.